This proactive approach sets the foundation for lasting success
The FDA is evaluating GLP-1 drugs like Ozempic, Wegovy, and Mounjaro for safety following anecdotal reports of suicidal ideation and hair loss
1 billion CFU Palmitoylethanolamide (PEA)
If you are considering stopping GLP-1 therapy, discuss a structured monitoring plan with your GP or specialist, including regular checks of HbA1c, weight, blood pressure and lipids
In addition, many of these patients will have additional risk factors for delayed gastric emptying (for example, diabetes or obesity) which must be taken into consideration
Originally developed to treat Type 2 diabetes, these medications have made headlines for their remarkable ability to help people shed stubborn pounds and feel more in control of their health